Sarra Setrerrahmane

Nanjing, 210033, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

ACE1-targeting peptide Acein ameliorates UV-induced skin damage and aging in vivo and in vitro via downregulation of the pro-aging factor CLEC4G.

ACE1-targeting peptide Acein ameliorates UV-induced skin damage and aging in vivo and in vitro via downregulation of the pro-aging factor CLEC4G.

Journal: Biochemical pharmacology
Published: September 01, 2025

A Novel Nuclear-Localized Micropeptide, MP60, Promotes Hepatocellular Carcinoma Progression via the Epithelial-Mesenchymal Transition.

A Novel Nuclear-Localized Micropeptide, MP60, Promotes Hepatocellular Carcinoma Progression via the Epithelial-Mesenchymal Transition.

Journal: Cancers
Published: August 13, 2025

A peptide-salinomycin conjugate with a bystander effect reduces the stemness characteristics of ovarian cancer cells and enhances drug sensitivity.

A peptide-salinomycin conjugate with a bystander effect reduces the stemness characteristics of ovarian cancer cells and enhances drug sensitivity.

Journal: European journal of medicinal chemistry
Published: May 16, 2024

A multifunctional antibody fusion protein 57103 targeting CD24, IL-4R, and αvβ3 for treating cancer and regulating the tumor microenvironment.

A multifunctional antibody fusion protein 57103 targeting CD24, IL-4R, and αvβ3 for treating cancer and regulating the tumor microenvironment.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 15, 2024

Nucleic acid drugs: recent progress and future perspectives.

Nucleic acid drugs: recent progress and future perspectives.

Journal: Signal transduction and targeted therapy
Published: October 31, 2023

The peptide Acein promotes dopamine secretion through clec-126 to extend the lifespan of elderly C. elegans.

The peptide Acein promotes dopamine secretion through clec-126 to extend the lifespan of elderly C. elegans.

Journal: Aging
Published: May 08, 2023

Micropeptide MIAC inhibits the tumor progression by interacting with AQP2 and inhibiting EREG/EGFR signaling in renal cell carcinoma.

Micropeptide MIAC inhibits the tumor progression by interacting with AQP2 and inhibiting EREG/EGFR signaling in renal cell carcinoma.

Journal: Molecular cancer
Published: July 22, 2022

Trends in insulin resistance: insights into mechanisms and therapeutic strategy.

Trends in insulin resistance: insights into mechanisms and therapeutic strategy.

Journal: Signal transduction and targeted therapy
Published: May 31, 2022

Cancer-related micropeptides encoded by ncRNAs: Promising drug targets and prognostic biomarkers.

Cancer-related micropeptides encoded by ncRNAs: Promising drug targets and prognostic biomarkers.

Journal: Cancer letters
Published: February 17, 2022

Integrins as attractive targets for cancer therapeutics.

Integrins as attractive targets for cancer therapeutics.

Journal: Acta pharmaceutica Sinica. B
Published: September 22, 2020

Accurate control of dual-receptor-engineered T cell activity through a bifunctional anti-angiogenic peptide.

Accurate control of dual-receptor-engineered T cell activity through a bifunctional anti-angiogenic peptide.

Journal: Journal of hematology & oncology
Published: December 18, 2017

Novel production method of innovative antiangiogenic and antitumor small peptides in Escherichia coli.

Novel production method of innovative antiangiogenic and antitumor small peptides in Escherichia coli.

Journal: Drug design, development and therapy
Published: November 30, 2017
Showing 1-12 of 18

Last Updated: 09/26/2026